Trials / Completed
CompletedNCT04574479
Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach
Impact of Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Opioid Consumption in Total Hip Arthroplasty Interventions by Posterior Approach
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
Find the impact of supra-inguinal fascia iliaca compartment block on postoperative pain management after total hip arthroplasty by posterior surgical approach
Detailed description
ASA physical status 1, 2 and 3 patients scheduled to undergo elective surgery of total hip arthroplasty under spinal anesthesia. The investigators would like to study the impact of supra-inguinal fascia iliaca block on postoperative pain management after total hip arthroplasty by posterior surgical approach. The principal investigator perform this block with ultrasound technique. The investigators also want to observe if this loco-regional new approach to fascia iliaca block could have influence on opioid side effects, postoperative nausea and vomiting, length of hospitalisation and first mobilisation side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Supra-inguinal fascia iliaca compartment block | Ultrasound guided loco-regional technique as described by Desmet et al. Fascia iliaca compartment block with in-plane 40 ml ropivacaine 0,375% injection between the ilio-psoas muscle and the internal oblique muscle. Patients in SFICB group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump |
| DRUG | Multimodal analgesia and PCA morphine pump | Patients in placebo group have classical multimodal approach to postoperative analgesia with morphine administration by PCA pump |
Timeline
- Start date
- 2020-12-16
- Primary completion
- 2021-09-01
- Completion
- 2021-09-02
- First posted
- 2020-10-05
- Last updated
- 2022-05-17
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04574479. Inclusion in this directory is not an endorsement.